Current Issue: 2023,Vol.31,NO.18 35
[3335-3341] LncRNA IQCH-AS1 inhibits proliferation of progesterone-resistant endometrial carcinoma cells by regulating miR-494-3p/ARID1A axis
[QIANG Xian,OUYANG Jun,WANG Haizhen,GE Sumei]
2023 18 [Abstract]()
[3342-3346] Study on the targeting of the B subunit of calmodulin phosphatase in liver cancer
[HAN Lifang,TIAN Shuhong]
2023 18 [Abstract]()
[3347-3352] Experimental study on inhibitory effect of TGF-βRⅡ receptor knockout CLDN18.2 CAR T cells on gastroesophageal junction carcinoma
[LI Shun,FAN Hua,YANG Yongxu,CAI Yingbin]
2023 18 [Abstract]()
[3353-3359] miR-24-3p expressed in osteosarcoma and inhibited the proliferation,invasion and migration of osteosarcoma cells
[WAN Ningjun1,TAO Yamei2,HAO Bin1,XU Shaowei1,WANG Zhen1]
2023 18 [Abstract]()
[3359-3365] Mechanical studies of the effects of circ-BAX.3 and circ-BAX.11 in inhibiting acute myeloid leukemia cells
[XING Zengwen1,WANG Wenfang1,SHI Danni2,LI Jiawei1,YAO Qi1,HAN Yanmei1,ZHANG Zhengyi3]
2023 18 [Abstract]()
[3366-3370] Ginkgetin induces ferroptosis of glioma cells by inhibiting Nrf2/HO-1/GPX4 signaling pathway
[ZHAO Yinsheng,BAO Long,SUN Tielin,LI Yang]
2023 18 [Abstract]()
[3371-3375] Ginsenoside Rd affects the proliferation and apoptosis of colon cancer SW480 cells by regulating the expression of lncRNA MAGI1-IT1
[KOU Weizheng,WANG Fang,ZHAO Hongke,ZHANG Lin,HUANG Haibo,KOU Xiaoge]
2023 18 [Abstract]()
[3376-3383] Prognostic analysis of pyroptosis and molecular mechanism of GZMB in acute myeloid leukemia based on TCGA and GTEx database
[DANG Qingxiu1，LI Yang2，GUO Yanting1，SHEN Yangling1，GU Weiying1]
2023 18 [Abstract]()
[3383-3388] Expression of PHF1 in colorectal cancer and its effects on proliferation,apoptosis,invasion and epithelial mesenchymal transformation of cancer cells
[ZHAO Jiangang,ZHAO Guangyuan,BAO Shuangzhen,LIU Yifen]
2023 18 [Abstract]()
[3388-3394] Analysis of the correlation between immune checkpoint inhibitor pneumonia and immunotherapeutic efficacy in non-small cell lung cancer
[ZHANG Li1，2,WANG Qiang3,HU Yan4,XIANG Zhuo3,GUO Yu3,BI Jingwang3]
2023 18 [Abstract]()
[3395-3399] FDXR and Nrf2 expression as predictive biomarkers for therapeutic response to chemoradiation in esophageal squamous cell carcinoma:A triple-center prospective clinical trial
[LIU Hong1，2,ZHAO Hongke3,QIN Sheng4,HOU Jun4,LI Dan4,LI Hua2,ZHENG Maojia2,CHEN Jing4]
2023 18 [Abstract]()
[3400-3404] Efficacy of anlotinib combined with radiofrequency ablation in the second-line treatment of advanced lung squamous cell carcinoma in the elderly
[CUI Lin,LIU Jianjun,JIANG Yong,LIU Xingxiang,HE Xuejun]
2023 18 [Abstract]()
[3405-3411] The expression of lncRNA LINC00460 in colorectal cancer tissues and its impact on cell proliferation,invasion and migration ability
[LI Qing1,CUI Facai1,YANG Hongjie2,ZHAO Weifeng2]
2023 18 [Abstract]()
[3411-3415] Efficacy analysis of neoadjuvant chemotherapy alone in the treatment of advanced low rectal cancer
[WANG Shaoyi，BAI Qiangshan，CHEN An]
2023 18 [Abstract]()
[3416-3420] Effect of preoperative skeletal muscle fat infiltration on postoperative complications of gastric cancer:A propensity score matching study
[WANG Siqi1,DING Yi1,LI Xi2,LEI Zhixin1]
2023 18 [Abstract]()
[3420-3427] The expression of E-cadherin,Vimentin,and mismatch repair related proteins in gastric cancer tissue and their relationship with patient prognosis
[ZHANG Lei1,SUN Xiaona2,ZHANG Li3,GAO Yuanyuan4,SHEN Zhihua5]
2023 18 [Abstract]()
[3427-3431] Clinical characteristics and prognostic analysis of MLL-AF4 positive acute leukemia patients
[ZHANG Meixiang，WANG Chunjian，SHI Lin，LI Yan，REN Hanyun]
2023 18 [Abstract]()
[3432-3436] Comparison of the efficacy of venetoclax combined azacitidine regimen and combination of decitabine and CAG regimen in acute myeloid leukemia unfit for standard chemotherapy
[SUN Li1,YE Shaojie2,ZHOU Nan1,CUI Weiguang1,QI Jiaxu1,LIU Xiaojun1,LUO Jianmin1,YANG Lin1]
2023 18 [Abstract]()
[3437-3442] Clinical characteristics and prognosis of primary central nervous system lymphoma
[GAO Jing，HAO Miaowang，YAN Xueqian，JI Yueru，TIAN Jing，XIAO Fang，LIU Li]
2023 18 [Abstract]()
[3442-3446] Exploration and evaluation of the radiotherapy plan for glioma
[WANG Peipei,LI Jinkai,LI Caihong,CAO Yuandong,CHANG Zhigang,GU Xiaohuan,DI Xiaoke,YANG Yan]
2023 18 [Abstract]()
[3447-3450] Dosimetric comparison of different treatment plan optimization methods in Gamma Knife treatment of acoustic neuroma
[CAI Juntao,CHEN Jing,LI Peng,LI Yang,ZHANG Zhujun,XU Yunbo]
2023 18 [Abstract]()
[3450-3454] Using two sample Mendelian randomization method to explore the causal relationship between tea intake and the risk of bladder cancer
[CHAI Hongqiang1,PANG Lei2,WU Ming1,LI Fei1,SHAO Jinkai2]
2023 18 [Abstract]()
[3455-3460] Expression of TRMT1 in prostate cancer tissues and its correlation with immune cell infiltration
[YUAN Chao1,WANG Lei2,WENG Xiaodong2,LI Mengbo1,LIU Xiuheng2,LI Youkong1]
2023 18 [Abstract]()
[3461-3467] The clinical value of distinguishing parotid pleomorphic adenoma and adenolymphoma based on the intratumoral and peritumoral CT radiomics models
[LIU Qifeng,DING Zhimin,YAO Qi,CHEN Peng,ZHOU Yanyan,ZHANG Chengmeng]
2023 18 [Abstract]()
[3468-3472] Predictive value of MRI multi-parameter quantitative analysis for malignant transformation of sinonasal inverted papilloma
[ZHANG Duo1,ZHOU Jin2,WU Yan1,GUO Ying1,LIU Ruichao1,XU Jin'e1，LIU Chong1]
2023 18 [Abstract]()
[3473-3480] Value of whole tumor volume ADC nomogram in diagnosing high-grade endometrial carcinoma
[DENG Ying1,DAI Qiang1,WANG Yin1,LI Zhihao1,ZHAO Tingting2,LIANG Yi1,YAN Bin1]
2023 18 [Abstract]()
[3481-3485] An analysis of malignant tumors incidence and mortality in Fuzhou,2018
[LI Hong,XU Youqiong,ZHENG Wanhui,LU Lu]
2023 18 [Abstract]()
[3488-3492] The progress of application of cerium oxide nanomaterials in tumor therapy
[YANG Min1,ZHANG Xuelin2,JIA Dexin1,DING Meijuan1,YU Yan1]
2023 18 [Abstract]()
[3493-3497] Role of Fusobacterium nucleatum in the development,diagnosis and treatment of colorectal cancer
[HUANG Ting1,2，LI Peihua1,2，CHEN Zhixiu1,2，PU Shiming1,2,3，ZHOU Zuping1,2,3]
2023 18 [Abstract]()
[3497-3501] Advances in research on the relationship between 5-hydroxytryptamine and cancer
[HUANG Shuting1,WU Xiaoxue2,MEI Yong3,LI Qinghai3,SONG Mei2,HE Weiling3,4]
2023 18 [Abstract]()
[3502-3507] Research advances of cuproptosis and copper complexes in antitumor therapy
[LIU Wei1,ZHANG Yangqiurong1,LI Li1,CAO Junyu1,CHEN Xihua2,YANG Kunxian1]
2023 18 [Abstract]()
[3507-3511] Research progress on application of enhanced recovery after surgery in perioperative period of ovarian cancer
[LI Jinke,OUYANG Ling]
2023 18 [Abstract]()
[3512-3519] Research progress of traditional Chinese medicine nano-preparations in tumor immunotargeted therapy
[LI Jiaxiang1,LI Fen2]
2023 18 [Abstract]()
[3519-3523] Role of PD-1/PD-L1 pathway,Th17 and Tregs cells in tumor immunity
[ZHANG Lanfang,ZHANG Mingjuan,XU Jinxiu,LI Shan,CHEN Yu,WANG Wenjing,YANG Juntian,LI Shengyun,GU Meiling]
2023 18 [Abstract]()
[3524-3528] Research progress on the role of SMC4 in signal pathways and tumor diseases
[CAI Weiwen1,2,YU Zeyuan2,YANG Hanteng2,YU Yanmei1,JIAO Zuoyi1,2]
2023 18 [Abstract]()